Get started

Marijuanastock

Planet 13 Holdings | PLNH | Long at $0.39The marijuana sector has taken a beating over the last few years, yet certain companies may provide value and dominate the space in the future. Enter Planet 13 Holdings $OTC:PLNH. This OTC play warrants extreme caution, though. It's either going to zero or could produce massive returns. My personal logic is not to bet the farm with any OTC play, but maybe an old goat ... and potentially buy the farm in the future. From a technical analysis perspective, my selected historical simple moving average (SMA) line is approaching the current price of $0.39. Frequently, as this SMA line and price get closer to each other, there is a pop in the price. Fundamentally, financial growth is anticipated. Financial highlights from the Q3 2024 report state that the company's revenue was $32.2 million as compared to $24.8 million, an increase of 29.7%. The increase in sales was driven by the addition of Florida as well as strong sales in Illinois. Gross profit was $16.7 million or 51.9% as compared to $11.1 million or 44.7%. Free cash flow: $108,807 million. Operationally, OTC:PLNH looks pretty good on paper. Marijuana legalization in the US is only going to expand. It's inevitable given the changing sentiment around the topic. If OTC:PLNH can do well in this space and is able to continue to grow, this ticker could get very interest. Thus, at $0.39, OTC:PLNH is in a personal buy zone. Target #1: $0.55 Target #2: $0.75 Target #3: $1.00 Target #4: $5.75 (very long-term outlook if legalization spreads...)
OTC:PLNHLong
by WorthlessViews
WM Technology | MAPS | Long at $1.00WM Technology NASDAQ:MAPS provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. After it's de-SPAC in 2020, it soared to $29.50 and now can be found for around $1.00. It's been consolidating at these lows for almost two years, and it may be gaining algorithmic traction for a move soon based on my selected simple moving average (SMA). Often (but not always), when this SMA gets close to the price, there is a pop to the historical SMA. Currently, it is in a personal buy zone at $1.00. Target #1 = $1.50 Target #2 = $2.00
NASDAQ:MAPSLong
by WorthlessViews
Tilray® to Import Medical Cannabis in the UKTilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom Grow Pharma will distribute Tilray’s GMP-certified medical cannabis products across the UK New UK agreement gives doctors and patients access to a sustainable supply of Tilray’s pharmaceutical-grade medical cannabis products Tilray expects to have a range of GMP-certified, medical cannabis products available for patients in the UK by March 2021. finance.yahoo.com
NASDAQ:TLRY
by AlenCiken
Tilray Rally As Georgia Runoffs Signal Democratic SenateMarijuana Stocks Rally As Georgia Runoffs Signal Democratic Senate Tilray, Inc. surge on hopes Democrats' win in Georgia could spark US legalization Tilray, Inc. surged on Wednesday following the early results of Georgia’s key Senate runoffs that could open the door to federal cannabis reform. With Democratic candidate Raphael Warnock claiming victory in his race against incumbent Sen. Kelly Loeffler (R -GA) and Democratic challenger Jon Ossoff winning his race against GOP Sen. David Perdue, Democrats took control of the Senate. That fuels hopes that prior roadblocks, including refusal on the part of Senate Majority Leader Mitch McConnell to bring cannabis reform bills to the chamber, could be removed to move legalization efforts forward on a national level. the change of Senate control would catalyze constructive changes for the sector. Democratic control of the Senate, “could help provide better access to capital, alleviate operating headwinds, and help drive industry growth.” more moderate reform could come first, perhaps in the form of a modified Strengthening the Tenth Amendment Through Entrusting States (STATES) Act, which could allow cannabis companies to access traditional banking and financial services and alleviate burdensome federal taxes. “To the extent that the industry is presented with an opportunity to lobby for either of these measures, we would expect a consensus to form around the STATES Act over the MORE Act,” she said. finance.yahoo.com Key to that growth will be the speed in which states that voted to legalize cannabis set up policy frameworks, and at a federal level, which policy proposals receive the largest attention from legislators. potential reforms range from mild banking reforms through the SAFE Banking Act, which would allow the industry to tap traditional financing and banking, to more progressive agenda goals like federal decriminalization and criminal expungements through the Marijuana Opportunity Reinvestment and Expungement (MORE) Act. A combination deal could also be pushed through. With New Jersey legalizing through a ballot initiative this November and New York increasingly looking likely to follow with legalization, according to New York Gov. Andrew Cuomo’s State of the State address. finance.yahoo.com
NASDAQ:TLRY
by AlenCiken
MJ Analytics generates six figure sales increaseMJ Analytics, an Akerna product built on Domo's modern BI platform, generates six figure sales increase Within less than 90 days of launching MJ Analytics, the platform has generated a six figure increase in sales and helped clients reduce manual reporting workflows by 90% through the use of scheduled reports. With a 95% positive product feedback based on recent surveys, MJ Analytics is proving its value as a first-of-its-kind actionable insights product. Since launch, MJ Analytics has: Processed a total of 5.1 million queries Averaged 3.6k queries a day with peaks of 20k queries during month ends Signed up 40 clients for Premium Analytics, through either a trial or paid subscription finance.yahoo.com New Year's Eve Marks Biggest Cannabis Sales Day of 2020 The Christmas holiday period (12/18-12/24) generated $427 million . Traditionally, the Friday preceding Christmas is the biggest sales day of the period. However, this year the Wednesday before Christmas (12/23) saw the most significant bump in sales with a 76% increase in daily sales. Totaling $87.3 million, the Wednesday before Christmas was the third-largest sales day of the year, only slightly behind Green Wednesday with $87.4 million. Previously projected to see depressed sales due to an anticipated decrease in group gatherings and parties as the result of COVID-19 restrictions, New Year's Eve exceeded all expectations. The year-end holiday saw approximately $89.4 million in sales, easily surpassing Green Wednesday and becoming the biggest cannabis sales day of the year. finance.yahoo.com
K
by AlenCiken
Cannabis Strategic Ventures - $NUGS Weekly ChartNuG$ acts as a holding company developing a portfolio of profitable subsidiaries operating in the legalized cannabis industry. They only operate in those states where cannabis is legalized and regulated under applicable state laws, and/or has been de-criminalized for medical use and/or legalized for recreational use. Currently, their subsidiary holdings are considered non-operational. $NUGS subsidiaries include: ● Pure Applied Sciences, Inc., a Delaware corporation engaged in the marketing and sales of its “PureOrganics™” brand of cannabis oils and related accessories; ● Fitamins, Inc., a Wyoming corporation, engaged in the marketing and sale of a brand of health and wellness products containing hemp-based CBD; and, ● Lyxr™, a brand of based luxury skin, hair and body products containing hemp-based CBD and other Phyto cannabinoids and other natural ingredients providing high-performing skin, hair and body topical solutions; and, ● BudHire, a staffing solution brand operating in Washington and California that provides temporary, long term and permanent staffing solutions for the Cannabis industry; and, ● NUGS Farm North owns 16 cannabis cultivation licenses, one nursery license, one distribution license, and one processing license in Northern California. ● FLORAH, a CBD only retail store conceptualized for launch in Los Angeles. Resources cannabisstrategic.com cannabisstrategic.com www.sec.gov Important Notes below www.sec.gov Results of Operations For the three months ended June 30, 2020 compared to fiscal year ended June 30, 2019. Revenues and Cost of Revenues Total revenues were $3,372,537 for the three months ended June 30, 2020 as compared to $161,158 for the three months ended June 30, 2019, an increase of $3,211,379. The increase in revenues was due to our sales from sale of Cannabis products and income from BudHire staffing services. Cost of revenues were $2,477,285 or 73.45% of total revenues for the three months ended June 30, 2020, versus $184,234 or 114.32% of total revenues for the three months ended June 30, 2019. This increase in costs of sales was due to our BudHire operations, whereby we invoice our staffing clients, who pay us a fee, and we account for the costs of paying placed employees for the staffing services provided and the cost to grow and harvest the cannabis in NUGS Farm North. Gross Profit Total gross profit was $895,252 for the three months ended June 30, 2020. This compares to total gross loss of $(23,076) for the three months ended June 30, 2019. Total gross profits for the three months ended June 30, 2020 as compared to 2019 reflect an increase of $918,328. Operating Expenses Total operating expenses were $2,312,505, for the three months ended June 30, 2020, as compared to $2,104,115 for the three months ended June 30, 2019. This increase was primarily due to more leases expense in the NUGS Farm North for the three months ended June 30, 2020. Other Income (Expense) Other income (expense) for the three months ended June 30, 2020 was income of $19,906 as compared with expense of ($187,544) for the three months ended June 30, 2019. This decrease in expense was due to reduction in loss in investing activity. Net Income (Loss) As a result of the factors discussed above, loss for the three months ended June 30, 2020 was ($1,420,032) as compared to a loss for the three months ended June 30, 2019 of ($2,308,156). Lower net-loss from 2019 which is a good sign Results of Operations For the fiscal year ended March 31, 2020 compared to fiscal year ended March 31, 2019. Revenues and Cost of Revenues Total revenues were $2,367,367 for the year ended March 31, 2020 as compared to $701,968 for the year ended March 31, 2019, an increase of $1,665,399. The increase in revenues was due to our sales from sale of Cannabis products and income from BudHire staffing services. Cost of revenues were $1,890,496 or 79.86% of total revenues for the year ended March 31, 2020, versus $680,917 or 97% of total revenues for the year ended March 31, 2019. This increase in costs of sales was due to our BudHire operations, whereby we invoice our staffing clients, who pay us a fee, and we account for the costs of paying placed employees for the staffing services provided and the cost to grow and harvest the cannabis in NUGS Farm North. Solid growth in Revenues atleast they are proving they can make the $$$ Gross Profit Total gross profit was $476,871 for the year ended March 31, 2020. This compares to total gross profit of $21,051 for the year ended March 31, 2019. Total gross profits for the year ended year ended March 31, 2020 as compared to 2019 reflect an increase of $455,820. Operating Expenses Total operating expenses were $9,053,806, for the year ended March 31, 2020, as compared to $21,136,801 for the year ended March 31, 2019. This decrease was primarily due to decrease in stock compensation expense of $1,471,277 for the year ended March 31, 2020 compare to $19,341,321 for the year ended March 31, 2019. Also, the Company incurred more leases expense in the NUGS Farm North for the year ended March 31, 2020. Other Income (Expense) Other income (expense) for the year ended March 31, 2020 was expense of ($461,456) as compared with expense of ($319,615) for the year ended March 31, 2019. This increase in expense was due to a loss in investing activity. Net Income (Loss) As a result of the factors discussed above, loss for the year ended March 31, 2020 was ($9,079,609) as compared to a loss for the year ended March 31, 2019 of ($21,432,605). This is a HUGE plus, the fact they lowered their net-loss from 21mil down to 10mil is a great sign lookingforward. Liquidity and Capital Resources As of June 30, 2020, our primary internal sources of liquidity were our working capital, which included cash and cash equivalents of $456,630, accounts receivable of $947,898, inventory of $2,955,039, and other receivables of $82.646. We have, during the period ended June 30, 2020, relied upon external financing arrangements to fund our operations. During the period ended June 30, 2020, we entered into several separate financing arrangements, to fund our Northern California cannabis grow and cultivation operation. Our ability to rely upon external financing arrangements to fund operations is not certain, and this may limit our ability to secure future funding from external sources without changes in terms requested by counterparties, changes in the valuation of collateral, and associated risk, each of which is reasonably likely to result in our liquidity decreasing in a material way. We intend to utilize cash on hand, loans and other forms of financing such as the sale of additional equity and debt securities and other credit facilities to conduct our ongoing business, and to also conduct strategic business development and implementation of our business plans generally. Our ability to timely complete our payment commitments is contingent upon our having to raise additional capital, which is not certain. Our ability to access additional funding through external financing arrangements is uncertain, and could possibly include terms and conditions pertaining to the valuation of collateral and associated risk, each of which is reasonably likely to result in our liquidity decreasing in a material way. For the three months ended June 30, 2020 compared to fiscal year ended June 30, 2019. Operating Activities Net cash used by operating activities for the three months ended June 30, 2020 was a use of ($1,348,691) and ($429,287) for the three months ended June 30, 2019. Investing Activities For the three months ended June 30, 2020 and 2019, investing activities were a use of cash of ($6,478) and ($2,735,147) respectively. Financing Activities For the three months ended June 30, 2020 and 2019, the net cash from financing activities was $1,323,335 and $3,304,601 respectively. For the fiscal year ended March 31, 2020 compared to fiscal year ended March 31, 2019. Operating Activities Net cash used by operating activities for the year ended March 31, 2020 was a use of ($7,642,740) and ($2,531,612) for the year ended March 31, 2019. Investing Activities For the years ended March 31, 2020 and 2019, investing activities were a use of cash of ($3,402,893) and ($144,200) respectively. Financing Activities For the years ended March 31, 2020 and 2019, the net cash from financing activities was $11,459,428 and $2,346,976 respectively. Off Balance Sheet Arrangements As of June 30, 2020 and March 31, 2020, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. Shares Reclass During the year ended March 31, 2020, the Company issued 7,277,856 shares to employees and non-employees for their stock compensation accrued as of March 31, 2019. Going Concern The Company sustained continued operating losses during the three months ended June 30, 2020 and 2019. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations, in which it has not been successful, and/or obtaining additional financing from its shareholders or other sources, as may be required. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the accompanying financial statements, the Company had an accumulated deficit of approximately $46.9 million at June 30, 2020, and net loss of $1.4 million for the three months ended June 30, 2020. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern. All in All if your still reading, I see potential for $NUGS to spike higher on the weekly. Still take profits when you see those narly gains! Acucumulation zone: .002500-->.10 Looking for a decent swing higher in the coming months. GLTA & may the NUGZ BE WITH US$
OTC:NUGSLong
by AaronX